Glenmark Pharmaceuticals competitors

Glenmark Pharmaceuticals's competitors include Magenta Therapeutics, Clementia Pharmaceuticals, Synthace and International Stem Cell Corporation
Add company...
Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Ltd. (GPL) is a research-driven, global, integrated pharmaceutical company. It is the leader in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
Magenta Therapeutics
Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.
Clementia Pharmaceuticals
Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
International Stem Cell Corporation
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.
Founding Date
Founding Date
1977
Founding Date
2016
Founding Date
2012
Founding Date
2011
Founding Date
2001
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Mumbai, IN HQ
Locations
Cambridge, US HQ
Locations
Westmount, CA HQ
Newton, US
Locations
London, GB HQ
Locations
Carlsbad, US HQ
Employees
Employees
7,000
Employees
578% increase
Employees
455% increase
Employees
462% increase
Employees
41
Valuation ($)
Valuation ($)
N/A
Valuation ($)
418.1 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
6.7 m
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
66
Facebook likes
3.8 k
Twitter followers
Twitter followers
N/A
Twitter followers
694
Twitter followers
N/A
Twitter followers
506
Twitter followers
10.1 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
$7.2b (FY, 2016)
Net income
Net income
N/A
Net income
N/A
Net income
($57.5m) (FY, 2016)
Net income
(£361.6k) (FY, 2013)
Net income
($1.1b) (FY, 2016)

Funding

Latest funding round
Latest funding round
N/A
Latest funding round
N/A
Latest funding round
$ 60m (about 3 years ago)
Latest funding round
$ 9.9m (11 months ago)
Latest funding round
N/A
Total funding raised
Total funding raised
N/A
Total funding raised
$ 150.5m
Total funding raised
$ 92.5m
Total funding raised
$ 16.2m
Total funding raised
$ 2.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Magenta Therapeutics
HQ
Cambridge, US
Employees
57↑ 8% increase

Magenta’s mission is to revolutionize stem cell transplant as the treatment for immune and blood diseases.

View company
Clementia Pharmaceuticals
HQ
Westmount, CA
Employees
45↑ 5% increase

Clementia Pharmaceuticals develops and commercializes therapeutics for people suffering from rare diseases.

View company
Synthace
HQ
London, GB
Employees
46↑ 2% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company
International Stem Cell Corporation
HQ
Carlsbad, US
Employees
41

International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.

View company